Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05894382

Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control

A Randomized Controlled Study on the Effectiveness, Safety and Adaptability of Double Helix Design Defocus Lens Spectacle Frames for Correction of Visual Acuity in Children and Adolescents, and Control of Myopia.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
236 (estimated)
Sponsor
Shanghai Eye Disease Prevention and Treatment Center · Academic / Other
Sex
All
Age
6 Years – 13 Years
Healthy volunteers
Not accepted

Summary

This study uses 1.585 double helix defocus lens PC lenses with a unique optical design that includes a globally coherent visible area and complementary left and right helices that can form clear images. In addition, the helical arrangement and reduced slit area can generate defocusing signals, inhibiting the development of myopia. Therefore, based on previous research, this study plans to evaluate the safety and effectiveness of 1.585 double helix defocus lens PC frame eyeglasses in controlling the progression of myopia in children and adolescents through a randomized controlled clinical trial.

Conditions

Interventions

TypeNameDescription
DEVICEDouble Helix Design Defocus Lens Spectacle (RACE)Double Helix Design Defocus Lens Spectacle wearing more than 10h/day.
DEVICEsingle-vision spetacle lenssingle-vision spetacle lens wearing more than 10h/day.

Timeline

Start date
2023-06-03
Primary completion
2026-08-31
Completion
2026-12-31
First posted
2023-06-08
Last updated
2025-12-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05894382. Inclusion in this directory is not an endorsement.